Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection have?
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection has 213 citations in the OpenAlex counts ScholarIQ stores.
When was Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection published?
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection has 2013 year in the ScholarIQ index.
What is the open-access status of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection?
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection has closed oa status in the ScholarIQ index.
What is the DOI of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection?
The DOI for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection is on the source record.
What is the PMID of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection?
The PMID for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection is on the source record.
What is the OpenAlex record for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection?
The OpenAlex for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection is on the source record.